封面
市場調查報告書
商品編碼
1936611

創傷性腦損傷評估市場機會、成長要素、產業趨勢分析及預測(2026年至2035年)

Traumatic Brain Injuries Assessment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球創傷性腦損傷評估市場預計到 2025 年將達到 23 億美元,預計到 2035 年將達到 40 億美元,年複合成長率為 5.2%。

創傷性腦損傷評估市場-IMG1

市場擴張的促進因素包括頭部創傷病例的增加、運動和軍事相關腦外傷病例的增多,以及神經影像和診斷技術的不斷進步。腦外傷評估涉及全面的臨床、認知和神經系統評估,以確定腦損傷的嚴重程度、功能影響和整體預後。神經系統測試、行為評估、影像技術和生物標記分析被整合在一起,以促進快速診斷、治療方案製定和預後判斷。此外,CT、MRI、EEG和基於生物標記的診斷技術的創新使得能夠更快、更準確地檢測出以前往往被忽視的輕度和中度腦外傷,從而進一步推動了市場成長。人工智慧驅動的分析、客觀的診斷工具和基於血液的篩檢解決方案的日益普及也在推動產業轉型。

市場覆蓋範圍
開始年份 2025
預測期 2026-2035
起始值 23億美元
預測金額 40億美元
複合年成長率 5.2%

由於其快速、經濟高效且非侵入性的評估能力,預計到2025年,篩檢設備市場佔有率將達到80.1%。這些設備對於在急診和臨床環境中早期發現和優先處理疑似腦損傷至關重要,因此得到了廣泛應用。

2025年,醫院領域佔據57.9%的市場佔有率,預計2026年至2035年間將達到24億美元。醫院是頭部創傷患者的主要治療中心,大量患者湧入使得先進的評估工具必不可少。道路交通事故和老齡化相關損傷的增加是導致住院人數上升的主要因素,進一步凸顯了對高效腦外傷評估解決方案的需求。

預計到2025年,美國創傷性腦損傷評估市場規模將達到8.816億美元。北美市場需求主要受意外事故、跌倒及其他原因導致的頭部損傷所驅動,這使得急救醫療服務提供者對快速且準確的診斷工具提出了更高的要求。醫院和急診對先進神經診斷解決方案的依賴,也持續推動美國市場的成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 產業影響因素
    • 促進要素
      • 創傷性腦損傷發生率不斷上升
      • 創傷性腦損傷評估的技術進步
      • 對創傷性腦損傷 (TBI) 評估的非侵入性設備的需求日益成長
      • 提高對創傷性腦損傷的認知
    • 產業潛在風險與挑戰
      • 熟練專業人員短缺
      • 評估設備高成本
    • 市場機遇
      • 攜帶式和照護現場評估工具的開發
      • 新興市場蘊藏著巨大的未開發需求
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 消費者洞察
  • 2024年定價分析
  • 未來市場趨勢
  • 價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 公司市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 重大進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章 2022-2035年按產品分類的市場估算與預測

  • 篩檢設備
    • 電腦斷層掃描(CT)
    • 磁振造影(MRI)
    • 其他篩檢設備
  • 監控設備
    • 顱內壓(ICP)監測
    • 腦組織氧分壓(pBrO2)

6. 依最終用途分類的市場估計與預測,2022-2035 年

  • 醫院
  • 診斷中心
  • 其他用途

第7章 2022-2035年各地區市場估算與預測

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章 公司簡介

  • BIOMERIEUX
  • BrainScope
  • COMPUMEDICS
  • FUJIFILM
  • GE Healthcare
  • InfraScan
  • INTEGRA
  • Natus Medical
  • NIHON KOHDEN
  • Oculogica
  • PHILIPS
  • RAUMEDIC
  • SIEMENS Healthineers
  • ZOLL Medical
簡介目錄
Product Code: 5931

The Global Traumatic Brain Injuries Assessment Market was valued at USD 2.3 billion in 2025 and is estimated to grow at a CAGR of 5.2% to reach USD 4 billion by 2035.

Traumatic Brain Injuries Assessment Market - IMG1

Market expansion is driven by the increasing prevalence of head injuries, the rising number of sports-related and military-associated TBIs, and ongoing advancements in neuroimaging and diagnostic technologies. Traumatic brain injury assessment involves a comprehensive clinical, cognitive, and neurological evaluation to determine the severity, functional impact, and overall outcome of brain injuries. It incorporates neurological tests, behavioral assessments, imaging techniques, and biomarker analysis to facilitate prompt diagnosis, treatment planning, and prognosis. The market is further fueled by innovations in CT, MRI, EEG, and biomarker-based diagnostics, enabling faster and more accurate detection of mild and moderate TBIs, which were often overlooked previously. Growing adoption of AI-driven analytics, objective diagnostic tools, and blood-based screening solutions is also reshaping the industry.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$2.3 Billion
Forecast Value$4 Billion
CAGR5.2%

The screening devices segment held an 80.1% share in 2025, due to their rapid, cost-effective, and non-invasive assessment capabilities. These devices are essential for early detection and prioritization of suspected brain injuries in emergency and point-of-care settings, driving their widespread adoption.

The hospitals segment held a 57.9% share in 2025, expected to reach USD 2.4 billion during 2026-2035. Hospitals remain the primary care centers for head injury patients, with high patient inflow demanding advanced assessment tools. Rising road traffic incidents and age-related injuries are key factors contributing to increased hospital admissions, reinforcing the need for efficient TBI evaluation solutions.

U.S. Traumatic Brain Injuries Assessment Market was valued at USD 881.6 million in 2025. North America's demand is largely fueled by head injuries stemming from accidents, falls, and other causes, creating significant pressure on emergency care providers to adopt rapid and accurate diagnostic tools. The reliance on advanced neurodiagnostic solutions in hospitals and emergency units continues to drive the U.S. market forward.

Key players in the Global Traumatic Brain Injury Assessment Market include Philips, BrainScope, INTEGRA, RAUMEDIC, Fujifilm, Natus Medical, GE Healthcare, BIOMERIEUX, Oculogica, NIHON KOHDEN, InfraScan, SIEMENS Healthineers, COMPUMEDICS, and ZOLL Medical. To strengthen their presence, companies are pursuing strategies such as launching advanced diagnostic tools with faster turnaround times, integrating AI and machine learning into imaging platforms, and developing non-invasive biomarker-based tests. Many firms are expanding geographically to access high-growth regions and forming partnerships with hospitals, research institutions, and emergency care providers. Investment in marketing campaigns, training programs for healthcare professionals, and after-sales support ensures broader adoption and improved clinical outcomes.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing incidence of traumatic brain injuries
      • 3.2.1.2 Technological advancements in traumatic brain injuries assessment
      • 3.2.1.3 Increasing demand for non-invasive devices for TBI assessment
      • 3.2.1.4 Rising awareness regarding traumatic brain injury
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Dearth of skilled professionals
      • 3.2.2.2 High cost of assessment devices
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of portable and point-of-care assessment tools
      • 3.2.3.2 Emerging markets with untapped demand
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Consumer insights
  • 3.7 Pricing analysis, 2024
  • 3.8 Future market trends
  • 3.9 Value chain analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Screening devices
    • 5.2.1 Computerized tomography (CT) scan
    • 5.2.2 Magnetic resonance imaging (MRI)
    • 5.2.3 Other screening devices
  • 5.3 Monitoring devices
    • 5.3.1 Intracranial pressure (ICP) monitoring
    • 5.3.2 Partial pressure of oxygen in brain tissue (pBrO2)

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Diagnostic centers
  • 6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 BIOMERIEUX
  • 8.2 BrainScope
  • 8.3 COMPUMEDICS
  • 8.4 FUJIFILM
  • 8.5 GE Healthcare
  • 8.6 InfraScan
  • 8.7 INTEGRA
  • 8.8 Natus Medical
  • 8.9 NIHON KOHDEN
  • 8.10 Oculogica
  • 8.11 PHILIPS
  • 8.12 RAUMEDIC
  • 8.13 SIEMENS Healthineers
  • 8.14 ZOLL Medical